This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Medtronic expects to get US antitrust approval for Covidien merger by the end of November

( October 29, 2014, 15:02 GMT | Official Statement) -- MLex Summary: Medtronic Vice President Geoff Martha said that the company expects to get US antitrust approval for its planned $42.9 billion acquisition of Covidien by the end of November, according to a regulatory filing by Covidien on Wednesday. Martha also said the company hopes for EU approval sometime in early December, and Chinese approval probably at the end of December. Regarding tax inversion, Martha said the company is growing faster outside the US than in the US, so the deal is about the strategy of the company, not taxes.Extract....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login